SGMO - (NASDAQ) |
$5.90
+ 0.03
|
Mar 10, 2010 |
2:02 PM ET |
Corporate Profile
Sangamo BioSciences, Inc. is the worldwide leader in the research, development and commercialization of
engineered zinc finger DNA-binding proteins for therapeutic gene regulation and therapeutic gene correction.
Our technology platform has multiple applications in human therapeutics and drug discovery.
| 
